Volpara Health Technologies Limited (ASX:VHT)


right-arrow Created with Sketch. -0.03 (-3.26%)
MCAP $223.8M
Last trade 16.10pm 21/01/2022 20mins delayed

Latest Announcements

20/01/2022VHTVolpara Health Technologies Limited
22/12/2021VHTVolpara Health Technologies Limited
22/12/2021VHTVolpara Health Technologies Limited
13/12/2021VHTVolpara Health Technologies Limited
13/12/2021VHTVolpara Health Technologies Limited
01/12/2021VHTVolpara Health Technologies Limited
24/11/2021VHTVolpara Health Technologies Limited
23/11/2021 Price SensitivePSVHTVolpara Health Technologies Limited

Company Overview

Volpara Health Technologies Limited is a New Zealand-based research, development, and manufacturing company that provides breast imaging analytics and analysis products. The Company is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The Company's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.

VHT in the news

Volpara Health Technologies (VHT) has signed its highest ever value contract which…
Volpara Health Technologies (VHT) enters into a deal with Natera to bring…
Volpara Health Technologies (VHT) pens a collaboration agreement with Invitae Corporation to…
Volpara Health Technologies (VHT) has been granted another patent from the European…

Search Previous Announcements